Senior Investigator, Lady Davis Institute
Urologist, Jewish General Hospital
Assistant Professor, Department of Surgery (Division of Urology), McGill University
Dr. Campeau completed her medical studies in 2005 and her urology residency in 2010 at McGill University. She then went on to pursue her clinical and research interest in voiding dysfunction at the Wake Forest Institute for Regenerative Medicine in North Carolina, where she obtained a PhD in the Department of Physiology and Pharmacology in 2013. She completed her clinical training at New York University in an accredited fellowship in Female Pelvic Medicine and Reconstructive Surgery. Her areas of specialization include neurogenic voiding disorders and incontinence, as well as pelvic reconstruction.
Dr. Campeau was recruited back as an Assistant Professor of Surgery at McGill University in 2013, where she joined the Jewish General Hospital Department of Urology for her research interest and expertise. She has been awarded the Royal College of Physicians and Surgeons of Canada Detweiler Travelling Fellowship, the American Urological Association Foundation Research Scholar Fellowship, theQuebec Urological Association Training Scholarship, the Canadian Urological Association Scholarship Foundation Salary Award and the Quebec Diabetes Start-up Research Fund. Most recently, she was awarded the Fonds de recherche Santé Québec Clinical Research Scholar Junior 1 Award which facilitates her research activities at the Lady Davis Institute. Dr. Campeau is actively involved in several research societies including the International Continence Society and the International Consultation on Incontinence Research Society.
Major Research Activities
Physiology and Pharmacology of the lower urinary tract.
Female Pelvic Medicine, voiding dysfunction and urogenital reconstruction.
Campeau L, Blouin K, Leclerc P, Alary M, Morissette C, Blanchette C, Serhir B, Roy E; SurvUDI Working Group. Impact of sex work on risk behaviours and their association with HIV positivity among people who inject drugs in Eastern Central Canada: cross-sectional results from an open cohort study. BMJ Open. 2018 Jan 31;8(1).
Mossa AH, Velasquez Flores M, Cammisotto PG, Campeau L. Succinate, increased in metabolic syndrome, activates GPR91 receptor signaling in urothelial cells. Cell Signal. 37:31-39, 2017.
Shamout S, Campeau L. Stress urinary incontinence in women: Current and emerging therapeutic options. Can Urol Assoc J. 2017 Jun;11(6Suppl2):S155-S158.